Lin Shen

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial

Yelena Y. Janjigian, Kohei Shitara, Markus Moehler et al. · The Lancet · 2021 · 2.7K citations · Full text

Chemotherapy Versus Chemotherapy, Esophageal Cancer, Gastrointestinal Oncology +7

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Trifluridine/Tipiracil (TAS-102) Monotherapy in Asian Patients With Previously Treated Metastatic Colorectal Cancer: The TERRA Study

Jianming Xu, Tae Won Kim, Lin Shen et al. · Journal of Clinical Oncology · 2017 · 247 citations

Cancer Management, Pharmacotherapy, Surgery +18

Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)

Lin Shen, Jin Li, Jianming Xu et al. · Gastric Cancer · 2014 · 241 citations · Full text

Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer

Yilin Li, Jifang Gong, Qiyue Zhang et al. · British Journal of Cancer · 2016 · 100 citations · Full text

Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Rui‐Hua Xu, Jin Li, Yuxian Bai et al. · Journal of Hematology & Oncology · 2017 · 84 citations · Full text